Device Trial Radar · NCT01853397
Evaluation of the Treatment of Adipose Tissue With Liposonix System (Model 2) Using a New Treatment Method
Last checked: Nov 20, 2026Latest source record: Apr 16, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Sponsor
- Lead sponsor
- Solta MedicalNot on our public-company list
- Sponsor type
- Industry
- First posted
- May 15, 2013
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety, efficacy, and tolerability of treatment with the Liposonix System (Model 2)using a single pass technique.
Conditions
- Subcutaneous Adipose Tissue
Interventions
Liposonix System (Model 2)Device
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Waist Circumference 12 Weeks After Treatment as Compared to BaselineTime frame: 12 weeks
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Solta Medical Aesthetic Center
Hayward, California
1 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.